Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
The progression of chronic liver diseases (CLD), irrespective of etiology, involves chronic
parenchymal injury, persistent activation of inflammatory response as well as sustained …
parenchymal injury, persistent activation of inflammatory response as well as sustained …
[HTML][HTML] Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
Y Iwakiri, J Trebicka - JHEP reports, 2021 - Elsevier
Portal hypertension, defined as increased pressure in the portal vein, develops as a
consequence of increased intrahepatic vascular resistance due to the dysregulation of liver …
consequence of increased intrahepatic vascular resistance due to the dysregulation of liver …
Liver sinusoidal endothelial cells: Physiology and role in liver diseases
J Poisson, S Lemoinne, C Boulanger, F Durand… - Journal of …, 2017 - Elsevier
Liver sinusoidal endothelial cells (LSECs) are highly specialized endothelial cells
representing the interface between blood cells on the one side and hepatocytes and hepatic …
representing the interface between blood cells on the one side and hepatocytes and hepatic …
[HTML][HTML] Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors
F Turon, EG Driever, A Baiges, E Cerda… - Journal of …, 2021 - Elsevier
Background & Aims Portal vein thrombosis (PVT) is a relatively frequent event in patients
with cirrhosis. While different risk factors for PVT have been reported, such as decreased …
with cirrhosis. While different risk factors for PVT have been reported, such as decreased …
Liver cirrhosis
EA Tsochatzis, J Bosch, AK Burroughs - The Lancet, 2014 - thelancet.com
Cirrhosis is an increasing cause of morbidity and mortality in more developed countries,
being the 14th most common cause of death worldwide but fourth in central Europe …
being the 14th most common cause of death worldwide but fourth in central Europe …
Hepatic microcirculation and mechanisms of portal hypertension
J Gracia-Sancho, G Marrone… - Nature reviews …, 2019 - nature.com
The liver microcirculatory milieu, mainly composed of liver sinusoidal endothelial cells
(LSECs), hepatic stellate cells (HSCs) and hepatic macrophages, has an essential role in …
(LSECs), hepatic stellate cells (HSCs) and hepatic macrophages, has an essential role in …
Sinusoidal communication in liver fibrosis and regeneration
G Marrone, VH Shah, J Gracia-Sancho - Journal of hepatology, 2016 - Elsevier
Cellular crosstalk is a process through which a message is transmitted within an individual
cell (intracellular crosstalk) or between different cells (intercellular crosstalk). Intercellular …
cell (intracellular crosstalk) or between different cells (intercellular crosstalk). Intercellular …
Assessing portal hypertension in liver diseases
A Berzigotti, S Seijo, E Reverter… - Expert review of …, 2013 - Taylor & Francis
Portal hypertension is a common complication of chronic liver diseases and is responsible
for most clinical consequences of cirrhosis, which represent the more frequent causes of …
for most clinical consequences of cirrhosis, which represent the more frequent causes of …
The endothelium as a driver of liver fibrosis and regeneration
E Lafoz, M Ruart, A Anton, A Oncins, V Hernández-Gea - Cells, 2020 - mdpi.com
Liver fibrosis is a common feature of sustained liver injury and represents a major public
health problem worldwide. Fibrosis is an active research field and discoveries in the last …
health problem worldwide. Fibrosis is an active research field and discoveries in the last …
[PDF][PDF] Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
L Verbeke, R Farre, J Trebicka, M Komuta… - …, 2014 - Wiley Online Library
The farnesoid X receptor (FXR) is a nuclear bile acid receptor involved in bile acid
homeostasis, hepatic and intestinal inflammation, liver fibrosis, and cardiovascular disease …
homeostasis, hepatic and intestinal inflammation, liver fibrosis, and cardiovascular disease …